Also known as: Anti-thymocyte globulin ATG
Antithymocyte immunoglobulin is indicated for:
Irrespective of gender only Adults (18 years old or older)
For this indication, the medical literature mentions below treatments (click for details):
Irrespective of gender only Adults (18 years old or older)
For this indication, the medical literature mentions below treatments (click for details):
Active ingredient Antithymocyte immunoglobulin is contraindicated in the following cases:
No gender/age discrimination
Active acute or chronic infections, which would contraindicate any additional immunosuppression.
Antithymocyte immunoglobulin is routinely used in combination with other immunosuppressive agents. Infections (bacterial, fungal, viral and protozoal), reactivation of infection (particularly CMV) and sepsis have been reported after antithymocyte immunoglobulin administration in combination with multiple immunosuppressive agents. In rare cases, these infections have been fatal.